{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:54:11Z","timestamp":1791050051775,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Menopause hormone replacement therapy (HRT) remains the main strategy for managing menopausal symptoms and preventing osteoporosis in postmenopausal women. However, its cardiovascular effects are complex and influenced by multiple factors. Early initiation of HRT within 10 years of menopause onset consistently demonstrates cardiovascular benefits, whereas delayed initiation may increase risks such as stroke and venous thromboembolism. Transdermal and bioidentical hormones generally show a safer cardiovascular profile compared to oral synthetic preparations. Current guidelines advocate for individualized therapy considering patient preferences and risk stratification. However, significant knowledge gaps remain regarding long-term safety, diverse populations, and optimized risk assessment tools. The development of a menopause-specific cardiovascular risk calculator could enhance patient-centred care and guide shared decision-making. This review synthesizes current evidence from major randomized trials, observational studies, and meta-analyses, highlighting the critical role of timing, hormone formulation, administration route, and baseline cardiovascular risk in determining HRT\u2019s cardiovascular outcomes. It also underscores the importance of precision medicine in optimizing cardiovascular and overall health outcomes for postmenopausal women using HRT.<\/jats:p>","DOI":"10.1093\/ehjopen\/oeag054","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:43:55Z","timestamp":1774529035000},"source":"Crossref","is-referenced-by-count":5,"title":["Hormone replacement therapy and cardiovascular risk in postmenopausal women"],"prefix":"10.1093","volume":"6","author":[{"given":"Isabella","family":"Blackburn","sequence":"first","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University , 4th Floor William Leech Building, Newcastle upon Tyne NE2 4HH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2975-6971","authenticated-orcid":false,"given":"Vijay","family":"Kunadian","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University , 4th Floor William Leech Building, Newcastle upon Tyne NE2 4HH ,","place":["UK"]},{"name":"Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundations Trust , Newcastle upon Tyne NE7 7DN ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"2026061302113408900_oeag054-B1","doi-asserted-by":"crossref","first-page":"107974","DOI":"10.1016\/j.maturitas.2024.107974","article-title":"Menopause transition and cardiovascular disease risk","volume":"185","author":"Uddenberg","year":"2024","journal-title":"Maturitas"},{"key":"2026061302113408900_oeag054-B2"},{"key":"2026061302113408900_oeag054-B3","volume-title":"UK Factsheet","author":"Foundation","year":"2024"},{"key":"2026061302113408900_oeag054-B4","first-page":"60","article-title":"Estrogen and cardiovascular disease","volume":"84","author":"Gersh","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"key":"2026061302113408900_oeag054-B5","doi-asserted-by":"crossref","first-page":"bqad079","DOI":"10.1210\/endocr\/bqad079","article-title":"Estrogen and the vascular endothelium: the unanswered questions","volume":"164","author":"SenthilKumar","year":"2023","journal-title":"Endocrinology"},{"key":"2026061302113408900_oeag054-B6","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/S2468-2667(19)30155-0","article-title":"Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data","volume":"4","author":"Zhu","year":"2019","journal-title":"Lancet Public Health"},{"key":"2026061302113408900_oeag054-B7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/2053369120957514","article-title":"The British menopause society & women's health concern 2020 recommendations on hormone replacement therapy in menopausal women","volume":"26","author":"Hamoda","year":"2020","journal-title":"Post Reprod Health"},{"key":"2026061302113408900_oeag054-B8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women\u2019s health initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"2026061302113408900_oeag054-B9","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women's health initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"2026061302113408900_oeag054-B10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the million women study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"2026061302113408900_oeag054-B11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/GME.0000000000001282","article-title":"Menopausal hormone therapy trends before versus after 2002: impact of the women's health initiative study results","volume":"26","author":"Crawford","year":"2018","journal-title":"Menopause"},{"key":"2026061302113408900_oeag054-B12","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"2026061302113408900_oeag054-B13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.lfs.2019.02.020","article-title":"Association between duration of endogenous estrogen exposure and cardiovascular outcomes: a population - based cohort study","volume":"221","author":"Farahmand","year":"2019","journal-title":"Life Sci"},{"key":"2026061302113408900_oeag054-B14","doi-asserted-by":"crossref","first-page":"e078784","DOI":"10.1136\/bmj-2023-078784","article-title":"Contemporary menopausal hormone therapy and risk of cardiovascular disease: swedish nationwide register based emulated target trial","volume":"387","author":"Johansson","year":"2024","journal-title":"BMJ"},{"key":"2026061302113408900_oeag054-B15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12905-023-02788-0","article-title":"The benefits and risks of menopause hormone therapy for the cardiovascular system in postmenopausal women: a systematic review and meta-analysis","volume":"24","author":"Gu","year":"2024","journal-title":"BMC Womens Health"},{"key":"2026061302113408900_oeag054-B16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCRESAHA.124.325639","article-title":"Preservation of vascular endothelial function in late-onset postmenopausal women","volume":"136","author":"Darvish","year":"2025","journal-title":"Circ Res"},{"key":"2026061302113408900_oeag054-B17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N Engl J Med"},{"key":"2026061302113408900_oeag054-B18","doi-asserted-by":"crossref","first-page":"e6409","DOI":"10.1136\/bmj.e6409","article-title":"Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial","volume":"345","author":"Schierbeck","year":"2012","journal-title":"BMJ"},{"key":"2026061302113408900_oeag054-B19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12916-016-0762-8","article-title":"Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study","volume":"15","author":"de Kat","year":"2017","journal-title":"BMC Med"},{"key":"2026061302113408900_oeag054-B20","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1210\/clinem\/dgab042","article-title":"Menopausal hormone therapy and cardiovascular disease: the role of formulation, dose, and route of delivery","volume":"106","author":"Shufelt","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026061302113408900_oeag054-B21","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"2026061302113408900_oeag054-B22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/GME.0000000000001326","article-title":"The kronos early estrogen prevention study (KEEPS): what have we learned?","volume":"26","author":"Miller","year":"2019","journal-title":"Menopause"},{"key":"2026061302113408900_oeag054-B23","doi-asserted-by":"crossref","first-page":"e12241","DOI":"10.1590\/1414-431x2023e12241","article-title":"Combined effect of physical exercise and hormone replacement therapy on cardiovascular and metabolic health in postmenopausal women: a systematic review and meta-analysis","volume":"56","author":"Sanchez-Delgado","year":"2023","journal-title":"Braz J Med Biol Res"},{"key":"2026061302113408900_oeag054-B24","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00404-022-06647-5","article-title":"Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic review","volume":"307","author":"Goldstajn","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"2026061302113408900_oeag054-B25","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1016\/j.transproceed.2013.06.011","article-title":"Hormone therapy in women after heart transplantation","volume":"45","author":"Kobashigawa","year":"2013","journal-title":"Transplant Proc"},{"key":"2026061302113408900_oeag054-B26","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of the north American menopause society","volume":"29","author":"The Hormone Therapy Position Statement of The North American Menopause Society\u201d Advisory P","year":"2022","journal-title":"Menopause"},{"key":"2026061302113408900_oeag054-B27","volume-title":"Menopause: identification and management"},{"key":"2026061302113408900_oeag054-B28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehaa1044","article-title":"Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists","volume":"42","author":"Maas","year":"2021","journal-title":"Eur Heart J"},{"key":"2026061302113408900_oeag054-B29","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/humrep\/deaa124","article-title":"Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies","volume":"35","author":"Zhu","year":"2020","journal-title":"Hum Reprod"}],"container-title":["European Heart Journal Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjopen\/advance-article-pdf\/doi\/10.1093\/ehjopen\/oeag054\/67636822\/oeag054.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/6\/2\/oeag054\/67636822\/oeag054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/6\/2\/oeag054\/67636822\/oeag054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:11:42Z","timestamp":1781331102000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjopen\/article\/doi\/10.1093\/ehjopen\/oeag054\/8555556"}},"subtitle":[],"editor":[{"given":"Salvatore","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjopen\/oeag054","relation":{},"ISSN":["2752-4191"],"issn-type":[{"value":"2752-4191","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,3]]},"article-number":"oeag054"}}